Sunday, November 10, 2013

So what's wrong if your drug-candidate is likely better-off as a dietary-supplement?

›
In a case-study , the Nov '13 issue of HBR showcases the dilemma of a R&D head grappling with the prospect of a failing clinical p...
Thursday, November 7, 2013

Les Propheties Pharmaceuticale : Prophesying on where the pharmaceutical outsourcing is headed

›
It is either an after-effect of all that powwow with the old-worldly Chippewa ( the ‘real-Indians’, who aren’t Indian really ;-) ) in the ...
Tuesday, October 15, 2013

Deal-Flow : Value-addition :: Silicon-rapids : Organic back-waters

›
Reacting to the rather weird scenario wherein some VCs are trashing their own brotherhood, Bruce Booth wonders in his latest article if t...
1 comment:
Wednesday, October 9, 2013

Isn't 'Syndicate' a worrisome term on an online crowd-funding platform?

›
A recent article by Lora Kolodny on Venture Capital Dispatch raises some interesting aspects on how VCs perceive the impact of likes of A...
Wednesday, September 25, 2013

End of the day it's all about the Benjamins', impressive TVPIs not withstanding!

›
In a wake-up call of sorts, Super LP Chris Douvos cautions GP universe that end of the day it's ' all about the Benjamins ', i...

We are all just prisoners here, of our own device!

›
Where does this notion that every mild ache or pain might be the harbinger of something particularly nasty, or even fatal, come from? asks ...
Thursday, September 12, 2013

Ambrosia for food, Palm-top engagement, Iterative decision making – A preview into evolving expectations of the healthcare consumer

›
Understanding consumer preferences has always been of paramount importance in most product segments. Within the pharmaceutical domain howe...
2 comments: